Related Experiment Videos

Allocation of resources between smoking cessation methods and lovastatin treatment of hypercholesterolaemia: based on

Pedro Plans-Rubió1

  • 1Evaluation Unit, Department of Health, General Direction of Public Health, Barcelona, Spain. pedro.plans@gencat.net

Pharmacoeconomics
|January 15, 2004
PubMed

Insights

Resource allocation for coronary heart disease prevention favors lovastatin treatment for hypercholesterolemia over nicotine cessation aids. This approach is more cost-effective and aligns with a non-utilitarian social welfare function.

Area of Science:

  • Health Economics
  • Public Health Policy
  • Cardiovascular Disease Prevention

Background:

  • Coronary heart disease (CHD) prevention requires strategic resource allocation between interventions like smoking cessation and hypercholesterolemia treatment.
  • The social welfare function (SWF) provides a framework for evaluating and prioritizing public health interventions based on societal values.

Purpose of the Study:

  • To determine optimal resource allocation between smoking cessation methods and lovastatin treatment for hypercholesterolemia in CHD primary prevention using the SWF.
  • To assess the cost-effectiveness of different intervention strategies under a non-utilitarian societal preference model.

Main Methods:

  • Utilized multiple logistic regression to derive the parameter epsilon, defining the SWF in Catalonia, Spain.
  • Evaluated three smoking cessation therapies (medical advice, nicotine gum, nicotine patch) and lovastatin (20, 40, 80 mg/day) for hypercholesterolemia (total cholesterol > 7.24 mmol/L).

Main Results:

  • The SWF exhibited a non-utilitarian form (epsilon = 1.58), prioritizing medical advice for smoking cessation and lovastatin treatment.
  • Medical advice combined with lovastatin showed higher epsilon values (2.8-2.9 men, 1.8-2.4 women) than nicotine substitution therapies (<0.9 men, <0.4 women).
  • This combined approach reduced treatment costs by 35% compared to a utilitarian strategy using nicotine patches and lovastatin.

Conclusions:

  • Lovastatin treatment for hypercholesterolemia warrants higher priority than nicotine substitution for smoking cessation based on cost-effectiveness and SWF analysis.
  • The study demonstrates the applicability of the SWF for resource allocation decisions, particularly when societal preferences are non-utilitarian.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...